Skip to main content
. 2022 Apr 4;24(8):1307–1367. doi: 10.1093/europace/euac030
Recommendation Consensus statement instruction Ref.
Targeted genetic testing is recommended as part of the diagnostic evaluation for index patients with isolated cardiac conduction disease (CCD/PCCD) or with concomitant structural heart disease or extracardiac disease, when there is early age of diagnosis or a suspicion of laminopathy, especially when there is documentation of a positive family history of CCD/PCCD. graphic file with name euac030ilf1.jpg Expert opinion
Targeted genetic testing may be considered as part of the diagnostic evaluation for index patients with isolated cardiac conduction disease (CCD/PCCD) or with concomitant structural heart disease or extracardiac disease, especially in the setting of a positive family history. graphic file with name euac030ilf2.jpg Expert opinion
Variant-specific genetic testing is recommended for family members and appropriate relatives following the identification of the disease-causative variant. graphic file with name euac030ilf1.jpg Expert opinion
Predictive genetic testing in related children may be considered from birth onward (any age) in specific settings. graphic file with name euac030ilf2.jpg Expert opinion